» Authors » Iain S McGregor

Iain S McGregor

Explore the profile of Iain S McGregor including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 246
Citations 5240
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bedoya-Perez M, Rahman M, McGregor I
Sci Rep . 2025 Mar; 15(1):7658. PMID: 40038355
Rats (Rattus norvegicus) exhibit defensive behaviors such as hiding, freezing, and fleeing when confronted with predators. They also may emit long-duration, flat frequency (~ 22-kHz), ultrasonic vocalizations (USVs) in response...
2.
Zhou C, Lavender I, Gordon R, McCartney D, Kevin R, Bedoya-Perez M, et al.
Sci Rep . 2025 Feb; 15(1):2649. PMID: 39905040
The Australian Capital Territory (ACT), a region that includes Australia's capital, Canberra, decriminalised small-scale cannabis cultivation and possession in January 2020. Here, we examined cannabis use and cultivation behaviours, experiences...
3.
McCartney D, Zhou C, Lavender I, Gordon R, Kevin R, Bedoya-Perez M, et al.
Drug Alcohol Rev . 2025 Jan; 44(2):588-601. PMID: 39778038
Introduction: In January 2020, the government of the Australian Capital Territory (ACT) decriminalised the possession and cultivation of cannabis for personal use. This study explored the driving-related attitudes, beliefs and...
4.
Arnold J, Occelli Hanbury-Brown C, Anderson L, Bedoya-Perez M, Udoh M, Sharman L, et al.
Neuropsychopharmacology . 2024 Nov; 50(3):586-595. PMID: 39528623
Medicinal cannabis is being used worldwide and there is increasing use of novel cannabis products in the community. Cannabis contains the major cannabinoids, Δ-tetrahydrocannabinol (Δ-THC) and cannabidiol (CBD), but also...
5.
Hurzeler T, Logge W, Watt J, DeMayo M, Suraev A, McGregor I, et al.
Contemp Clin Trials Commun . 2024 Sep; 41:101341. PMID: 39252861
Current treatments for alcohol use disorders (AUD) have limited efficacy. Recently, Cannabidiol (CBD) has been examined in a multitude of clinical settings. Preclinical and clinical results suggest that CBD might...
6.
Mills L, Arnold J, Suraev A, Abelev S, Zhou C, Arkell T, et al.
Harm Reduct J . 2024 May; 21(1):104. PMID: 38807133
Background: Cannabis was legalised for medical purposes in 2016. Uptake was initially slow, but since 2019 there has been a large increase in the number of Australians who have been...
7.
Bawa Z, Lewis D, Gavin P, Libinaki R, Joubran L, El-Tamimy M, et al.
Sci Rep . 2024 May; 14(1):11792. PMID: 38783008
Hand osteoarthritis (OA) is an irreversible degenerative condition causing chronic pain and impaired functionality. Existing treatment options are often inadequate. Cannabidiol (CBD) has demonstrated analgesic and anti-inflammatory effects in preclinical...
8.
McCartney D, Irwin C, Bawa Z, Palmer B, Sahinovic A, Delang N, et al.
Sports Med Open . 2024 May; 10(1):61. PMID: 38782848
Background: Exercise is known to improve health. However, it can be unpleasant, often inducing negative feelings, or 'affect'. Cannabidiol (CBD), a non-intoxicating constituent of the cannabis plant, has been reported...
9.
Sparkes E, Maloney C, Markham J, Dane C, Boyd R, Gilchrist J, et al.
ACS Chem Neurosci . 2024 May; 15(11):2160-2181. PMID: 38766866
Synthetic cannabinoid receptor agonists (SCRAs) are a growing class of new psychoactive substances (NPS) commonly derived from an -alkylated indole, indazole, or 7-azaindole scaffold. Diversification of this core (at the...
10.
Suraev A, McCartney D, Marshall N, Irwin C, Vandrey R, Grunstein R, et al.
Psychopharmacology (Berl) . 2024 May; 241(9):1815-1825. PMID: 38758300
Cannabis and its major constituents, Δ-tetrahydrocannabinol (THC) and cannabidiol (CBD), are being widely used to treat sleep disturbances. However, THC can cause acute cognitive and psychomotor impairment and there are...